Skip to main content

Advertisement

SpringerLink
Log in

miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease

  • Original Article
  • Published:
Immunogenetics Aims and scope Submit manuscript

Abstract

MicroRNA-455-5p (miR-455-5p) seems to have an anti-inflammatory role in the immune system since its expression is induced by IL-10 cytokine. Multiple sclerosis (MS) is a chronic demyelinating neurodegenerative disease of the central nervous system that is caused by an autoimmune inflammatory attack against the myelin insulation of neurons. The expression level of miR-455-5p and its role in MS pathogenesis has yet to be elucidated. We found that miR-455-5p expression was highly correlated with disease severity in MS patients. miR-455-5p expression inversely correlates with its inflammatory-predicted targets (MyD88 and REL) in relapse- and remitting-phase patients. Luciferase assays confirm that MyD88 and REL are direct targets of miR-455-5p. This study represents the first report of the miR-455-5p acts as an anti-inflammatory role in MS, at least partially through targeting MyD88 and REL. This study may provide important information for the use of miR-455-5p as a novel strategy to improve the severity of disease and control inflammation and attack in MS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Cardwell LN, Weaver BK (2014) IL-10 inhibits LPS-induced expression of miR-147 in murine macrophages. Adv Biol Chem 4:261–273

    Article  CAS  Google Scholar 

  • Chitnis T, Weiner HL (2017) CNS inflammation and neurodegeneration. J Clin Investig 127:3577–3587

    Article  PubMed  PubMed Central  Google Scholar 

  • Cunha F, Mohcada S, Liew F (1992) Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 182:1155–1159

    Article  CAS  PubMed  Google Scholar 

  • Du C et al (2009) MicroRNA miR-326 regulates T H-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10:1252–1259

    Article  CAS  PubMed  Google Scholar 

  • Ersoy E, Kuş C, Şener U, Coker I, Zorlu Y (2005) The effects of interferon-β on interleukin-10 in multiple sclerosis patients. Eur J Neurol 12:208–211

    Article  CAS  PubMed  Google Scholar 

  • Guo B (2016) IL-10 modulates Th17 pathogenicity during autoimmune diseases Journal of clinical & cellular immunology 7

  • Hilliard BA, Mason N, Xu L, Sun J, Lamhamedi-Cherradi SE, Liou HC, Hunter C, Chen YH (2002) Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J Clin Investig 110:843–850

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kouhkan F, Soleimani M, Daliri M, Behmanesh M, Mobarra N (2013) miR-451 up-regulation, induce erythroid differentiation of CD133+ cells independent of cytokine cocktails. Iran J Basic Med Sci 16:756

    PubMed  PubMed Central  Google Scholar 

  • Kouhkan F, Mobarra N, Soufi-Zomorrod M, Keramati F, Hosseini Rad SMA, Fathi-Roudsari M, Tavakoli R, Hajarizadeh A, Ziaei S, Lahmi R, Hanif H, Soleimani M (2016) MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1. J Med Genet 53:24–33

    Article  CAS  PubMed  Google Scholar 

  • Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1444

    Article  CAS  PubMed  Google Scholar 

  • Lassmann H (2018) Multiple sclerosis pathology. Cold Spring Harbor Perspect Med 8:a028936

    Article  CAS  Google Scholar 

  • Leibowitz SM, Yan J (2016) NF-κB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications. Front Mol Neurosci 9:84

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li Q-J, Chau J, Ebert PJR, Sylvester G, Min H, Liu G, Braich R, Manoharan M, Soutschek J, Skare P, Klein LO, Davis MM, Chen CZ (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129:147–161

    Article  CAS  PubMed  Google Scholar 

  • Liu T, Zhang L, Joo D, Sun S-C (2017) NF-κB signaling in inflammation. Signal Transduction Targeted Ther 2:17023

    Article  Google Scholar 

  • Marziniak M, Meuth S (2014) Current perspectives on interferon Beta-1b for the treatment of multiple sclerosis. Adv Ther 31:915–931

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matute C, Alberdi E, Domercq MA, Pérez-Cerdá F, Pérez-Samartin A, Sánchez-Gómez MAV (2001) The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 24:224–230

    Article  CAS  PubMed  Google Scholar 

  • Mc Guire C, Prinz M, Beyaert R, van Loo G (2013) Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology. Trends Mol Med 19:604–613

    Article  CAS  PubMed  Google Scholar 

  • Miranda-Hernandez S, Gerlach N, Fletcher JM, Biros E, Mack M, Körner H, Baxter AG (2011) Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis. J Immunol 187:791–804

    Article  CAS  PubMed  Google Scholar 

  • O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10:111–122. https://doi.org/10.1038/nri2708

    Article  CAS  PubMed  Google Scholar 

  • Obeidi N, Pourfathollah AA, Soleimani M, Zarif MN, Kouhkan F (2016) The Effect of mir-451 upregulation on erythroid lineage differentiation of murine embryonic stem cells. Cell J (Yakhteh) 18:165

    Google Scholar 

  • Park S-H, Cho G, Park S-G (2014) NF-κB activation in T helper 17 cell differentiation. Immun Netw 14:14–20

    Article  Google Scholar 

  • Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG, Rassenti L, Calin GA, Hagan JP, Kipps T, Croce CM (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66:11590–11593

    Article  CAS  PubMed  Google Scholar 

  • Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302

    Article  PubMed  PubMed Central  Google Scholar 

  • Ruan Q, Chen YH (2012) Nuclear factor-κB in immunity and inflammation: the Treg and Th17 connection. In: Current Topics in Innate Immunity II Springer, pp 207–221

  • Tak PP, Firestein GS (2001) NF-κB: a key role in inflammatory diseases. J Clin Investig 107:7–11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tasharrofi N, Kouhkan F, Soleimani M, Soheili ZS, Saber MM, Dorkoosh FA (2017) Survival improvement in human retinal pigment epithelial cells via fas receptor targeting by miR-374a Journal of cellular biochemistry

  • de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220

    Article  PubMed  Google Scholar 

  • Wu T, Chen G (2016) miRNAs participate in MS pathological processes and its therapeutic response mediators of inflammation 2016

  • Zhang J, Cheng Y, Cui W, Li M, Li B, Guo L (2014) MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 266:56–63

    Article  CAS  PubMed  Google Scholar 

  • Zhang H, Bi J, Yi H, Fan T, Ruan Q, Cai L, Chen YH, Wan X (2017) Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice. Immunol Cell Biol 95:593–600

    Article  CAS  PubMed  Google Scholar 

  • Zomorrod MS, Kouhkan F, Soleimani M, Aliyan A, Tasharrofi N (2018) Overexpression of miR-133 decrease primary endothelial cells proliferation and migration via FGFR1 targeting Experimental cell research

Download references

Acknowledgements

The authors are thankful for the valuable contribution of the patients included in the study. They are grateful to Dr. Abdorreza Naser Moghadasi for his excellent assistance and scientific advice in patient sample collection and patient categorization.

Funding

This work was supported by a research grant from the Stem cell Technology Research Center, Tehran, Iran.

Author information

Authors and Affiliations

  1. Stem Cell Technology Research Center, Tehran, Iran

    Shukoofeh Torabi, Mona Tamaddon, Mojtaba Asadolahi, Gelareh Shokri, Rezvan Tavakoli, Nooshin Tasharrofi, Reza Rezaei, Vahid Tavakolpour & Fatemeh Kouhkan

  2. Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran

    Nooshin Tasharrofi

  3. Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran

    Nooshin Tasharrofi

  4. School of Biology, College of Science, University of Tehran, Tehran, Iran

    Reza Rezaei

  5. Department of Biology, Basic Sciences Faculty, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran

    Hossein Sazegar

  6. Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center, P.O. Box: 15856-36473, Tehran, Iran

    Fatemeh Kouhkan

Authors
  1. Shukoofeh Torabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mona Tamaddon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mojtaba Asadolahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gelareh Shokri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rezvan Tavakoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nooshin Tasharrofi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Reza Rezaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vahid Tavakolpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hossein Sazegar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fatemeh Kouhkan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fatemeh Kouhkan.

Additional information

Shukoofeh Torabi and Mona Tamaddon are Shared first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Torabi, S., Tamaddon, M., Asadolahi, M. et al. miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease. Immunogenetics 71, 87–95 (2019). https://doi.org/10.1007/s00251-018-1087-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00251-018-1087-x

Keywords

Search

Navigation